| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/07/2011 | CN1526072B Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 09/07/2011 | CN102174574A Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor |
| 09/07/2011 | CN102174550A Recombinant ubiquitin ligase PTB-U-box fusion gene and expression vector and application thereof |
| 09/07/2011 | CN102174534A S. pneumoniae antigens |
| 09/07/2011 | CN102174533A Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof |
| 09/07/2011 | CN102174521A Human ribosomal protein molecules hRrp15p and preparation method and application thereof |
| 09/07/2011 | CN102174520A Interference nucleic acid molecule and application thereof |
| 09/07/2011 | CN102174518A Main cis-acting element of shrimp white spot syndrome virus (WSSV) iel promoter and transcription factor combined with same and application |
| 09/07/2011 | CN102174516A Molecular target for diagnosing and treating nasopharyngeal cancer related with Epstein-Barr virus (EBV) infection and application thereof |
| 09/07/2011 | CN102174515A Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 09/07/2011 | CN102174514A Double-stranded siRNA (Small Interfering Ribonucleic Acid) for suppressing Hmga2 gene expression and application thereof |
| 09/07/2011 | CN102174513A Mammal ribonucleic acid small molecular compound and application thereof |
| 09/07/2011 | CN102174479A Oncolytic virus for targeted treatment of human tumors and application thereof |
| 09/07/2011 | CN102174478A Photosensitizer binding protein/polypeptide and application thereof to photodynamic gene therapy |
| 09/07/2011 | CN102174184A Biodegradable polymer, preparation method thereof and nucleic acid drug delivery carrier |
| 09/07/2011 | CN102174099A Target protein for Alzheimer's disease and coding gene and application thereof |
| 09/07/2011 | CN102172408A Compositions and methods of inhibiting cell growth |
| 09/07/2011 | CN102172407A Rnai inhibition of serum amyloid a for treatment of glaucoma |
| 09/07/2011 | CN102172406A Intact minicells as vectors for DNA transfer and gene therapy in vitro and in vivo |
| 09/07/2011 | CN101597337B Conjugate of hydroxyalkyl starch and an active agent |
| 09/07/2011 | CN101543625B Use of CENP-E binding protein and its coding gene in preparing medicine for suppressing tumor proliferation |
| 09/07/2011 | CN101434657B Preparation and use of recombinant mtVEGF121/MAP30KDEL fusion noxioussubstance |
| 09/07/2011 | CN101429525B Antineoplastic invasion transfer function of snake venom metalloprotease inhibitors BJ46a and uses thereof |
| 09/07/2011 | CN101348787B Preparation and use of giant panda Ascaris schroederi antigen |
| 09/07/2011 | CN101220360B SiRNA sequence restraining caspase-3 gene expression |
| 09/07/2011 | CN101037691B CENP-E combined protein and encoding gene and application |
| 09/06/2011 | US8013211 Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell |
| 09/06/2011 | US8013146 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA) |
| 09/06/2011 | US8013145 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy |
| 09/06/2011 | US8013133 Genetic modification of targeted regions of the cardiac conduction system |
| 09/06/2011 | US8013126 84P2A9: a prostate and testis specific protein highly expressed in prostate cancer |
| 09/06/2011 | US8012946 Anti-angiogenic methods and compositions |
| 09/06/2011 | US8012945 Single chain fragment variable (scFv) antibody or an Fab antibody; screening phage-displayed antibodies for an ability to bind to a radiation-inducible neoantigen present on a cell |
| 09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
| 09/06/2011 | US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012469 Universal GM-CSF expressing bystander human K562 cell line |
| 09/06/2011 | US8012468 Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same |
| 09/01/2011 | WO2011106481A1 Dna dendrimers as thermal ablation devices |
| 09/01/2011 | WO2011105527A1 Nerve growth promoter |
| 09/01/2011 | WO2011105402A1 Short-chain cationic polyamino acid and use thereof |
| 09/01/2011 | WO2011104169A1 Compositions for targeted delivery of sirna |
| 09/01/2011 | WO2011084548A8 Methods and compositions for detecting recessive familial fsgs and uses thereof |
| 09/01/2011 | WO2010127195A3 Treatment of hemoglobin (hbf/hbg) related diseases inhibition of natural antisense transcript to hbf/hbg |
| 09/01/2011 | US20110213293 Ligands to radiation-induced molecules |
| 09/01/2011 | US20110213128 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 09/01/2011 | US20110213017 Targeted delivery of glycine receptors to excitable cells |
| 09/01/2011 | US20110213016 E2EPF Ubiquitin Carrier Protein-Von Hippel-Lindau Interaction and Uses Thereof |
| 09/01/2011 | US20110213014 Compositions and methods for topical delivery of oligonucleotides |
| 09/01/2011 | US20110213002 Macrocyclic diterpenes for treating conditions associated with protein kinase c |
| 09/01/2011 | US20110212895 Treatment of Cognitive and Learning Impairment |
| 09/01/2011 | US20110212529 Muscle-specific expression vectors |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212139 High-density lipoprotein coated medical devices |
| 09/01/2011 | US20110212135 Oligodeoxynucleotide and its use to induce an immune response |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212074 Myeloid colony stimulating factor and uses thereof |
| 09/01/2011 | US20110212059 Paramyxovirus vector encoding angiogenesis gene and use thereof |
| 09/01/2011 | US20110212058 Targeted modulation of gene expression |
| 09/01/2011 | US20110212055 Neurodegenerative disorders |
| 09/01/2011 | CA2789789A1 Dna dendrimers as thermal ablation devices |
| 09/01/2011 | CA2788600A1 Compositions for targeted delivery of sirna |
| 08/31/2011 | EP2362221A1 Antagonists of HMG1 for treating inflamatory conditions |
| 08/31/2011 | EP2361991A1 Detection of small nucleic acids |
| 08/31/2011 | EP2361988A1 Molecular marker for cancer stem cell |
| 08/31/2011 | EP2361982A1 Human gene encoding ubiquitin conjugating enzyme |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361978A1 Polypeptides capable of eliciting an immune reaction against cancer |
| 08/31/2011 | EP2361966A1 Mesoderm and definitive endoderm cell populations |
| 08/31/2011 | EP2361923A2 Oligoribonucleotides and ribonucleases for cleaving RNA |
| 08/31/2011 | EP2361921A2 Novel bicyclonucleoside and oligonnucleotide analogue |
| 08/31/2011 | EP2361635A2 Anti IgE vaccines |
| 08/31/2011 | EP2361309A1 Method |
| 08/31/2011 | EP2217208B1 Nucleic acid complex and nucleic acid delivery composition |
| 08/31/2011 | EP2193204B1 Compositions comprising lipophosphoramides and their uses in gene therapy |
| 08/31/2011 | EP2031057B1 SENSE OLIGONUCLEOTIDE CAPABLE OF CONTROLLING THE EXPRESSION OF iNOS AND COMPOSITION COMPRISING THE SAME |
| 08/31/2011 | EP1095140B1 Neurotrophic factors |
| 08/31/2011 | CN102171234A Photo-crosslinked nucleic acid hydrogels |
| 08/31/2011 | CN102170910A Novel use application of sugar chain-recognizing receptor |
| 08/31/2011 | CN102168088A T cell immunogen gene TI and applications thereof in foot-and-mouth disease protein subunit vaccine and inactivated vaccine |
| 08/31/2011 | CN102168085A SiRNA for inhibiting expression of miR-130b gene and expression vector and application of siRNA or/and expression vector to preparation of medicament for improving treatment effect of liver cancer |
| 08/31/2011 | CN102168076A An ubiquitin ligase and the application thereof |
| 08/31/2011 | CN102168074A Recombinant adenovirus and application thereof |
| 08/31/2011 | CN102166364A Inhibitor of calcium-independent phospholipase A2 used for treating oophoroma |
| 08/31/2011 | CN102166363A Application of miR-21 to preparing medicines for promoting healing of skin injury |
| 08/31/2011 | CN102166217A Use of Bordetella pertussis CpG-ODNs (CpG oligodeoxynucleotides) as medicine for preventing and treating asthma |
| 08/31/2011 | CN102166166A Method and application using compounds from fetal cells and tissues to improve skin condition |
| 08/31/2011 | CN101884794B Application of S100A16 gene in preparing medicaments for treating insulin resistance |
| 08/31/2011 | CN101781373B Salbutamol modified guanidinated chitosan and preparation method and application thereof |
| 08/31/2011 | CN101575616B Avian influenza and MD bivalent vaccine rMDV-HA virus strain and construction method |
| 08/30/2011 | US8008474 siRNA targeting KRAS |
| 08/30/2011 | US8008471 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 08/30/2011 | US8008470 Integrase cofactor |
| 08/30/2011 | US8008469 Antisense compound for inducing immunological tolerance |
| 08/30/2011 | US8008276 Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 08/30/2011 | US8008273 SHIP-deficiency to increase megakaryocyte progenitor production |
| 08/30/2011 | US8008271 Methods and compositions for treating gain-of-function disorders using RNA interference |